Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oklahoma Blood Institute (OBI) is the sixth-largest independent blood center in the United States, operating 17 donor centers and supplying blood products to over 240 hospitals and medical facilities across Oklahoma, Texas, and Arkansas[1][3][6][7]. As a non-profit blood provider, it works to ensure a safe and reliable blood supply, including whole blood, plasma, and platelets[1][7]. OBI does not have a therapeutic pipeline in the drug development sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oklahoma Blood Institute.